APBiotech Posts 13 Percent Hike in H1 Revenues | GenomeWeb

NEW YORK, Aug 7 – Amersham Pharmacia of London said Tuesday its Amersham Pharmacia Biotech unit posted overall sales of 325.1 million pounds ($460.2 million) in the first half of the year, up 13 percent from the same period a year ago.

Within APBiotech, the company reported a 22 percent increase in its protein purification separations business to 130 million pounds, a one percent increase in sales of laboratory products to 93 million pounds, and a nine percent increase in drug discovery sales to 71 million pounds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.